Abstract
The study of oncogene activation in naturally occurring human leukemias provides a useful approach to define the range of growth regulatory mechanisms used by hematopoietic stem cells. Recent analysis of the structural changes created by the Philadelphia chromosome translocation [t(9;22) — (q34;q11)] shows that two alternative regions of the BCR gene on chromosome 22 can be used as the breakpoint site. This results in two alternative subsets of exons of the BCR gene remaining on the Philadelphia chromosome, which can be joined by RNA splicing to a common set of exons of the ABL oncogene derived from chromosome 9 sequences. The resulting chimeric mRNAs encode a 210,000 MW protein in CML (P210BCR/ABL) and a 185,000 MW protein in ALL (P185BCR/ABL). Both proteins retain an active tyrosine kinase activity derived from the ABL portion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bell JC, Mahadevan LC, Colledge WH, et al (1987) Abelson-transformed fibroblasts contain nuclear phosphotyrosyl-proteins which preferentially bind to murine DNA. Nature 325:552–554
Chan LC, Karhi KK, Rayter SI et al (1987) A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 325:635–637
Clark SS, McLaughlin J, Crist WM, Champlin R & Witte ON (1987) Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science 235:85–88
Clark SS, McLaughlin J, Timmons M et al (1988) Expression of a distinctive BCR-ABL oncogene in Ph+ acute lymphocytic leukemia (ALL). Science 239:775–777
Cook WD, Fazekas de St. Groth B, Miller JFAP, MacDonald HR & Gabathuler R (1987) Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line. Molec Cell Biol 7:2631–2635
Cook WD, Metcalf D, Nicola NA, Burgess AW & Walker F (1985) Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41:677–683
Daley GQ, McLaughlin J, Witte ON & Baltimore D (1987) The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH-3T3 fibroblasts. Science 237:532–535
Davis RL, Konopka JB & Witte ON (1985) Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Molec Cell Bio 5:204–213
Fainstein E, Marcelle C, Rosner A et al (1987) A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330:386–388
Frackelton Jr AR, Ross AH & Eisen H (1983) Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells. Molec Cell Biol 3:1343–1352
Groffen J, Stephenson JR, Heisterkamp N et al (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93–99
Hermans A, Heisterkamp N, von Lindern M et al (1987) Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33–40
Janssen JW, Steenvoorden ACM, Lyons J, Anger B, Bohlke JU, Bos JL, Seliger H, Bartram CR (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 84:9228–9232
Kawasaki ES, Clark SS, Coyne MY et al (1988) Diagnosis of chronic myelogenous and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci in press
Konopka JB, Clark S, McLaughlin J, Nitta M, Kato Y, Strife A, Clarkson B & Witte ON (1986) Expression of the translocated c-abl gene in Phipositive B lymphoid cell lines from chronic myelogenous leukemia patients. Proc Natl Acad Sci 83:4049–4052
Konopka JB, Watanabe SM & Witte ON (1984) An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035–1042
Konopka JB, Watanabe SM, Singer J, Collins S & Witte ON (1985) Cell lines and clinical isolates derived from Phipositive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci 82:1810–1814
Kurzrock R, Shtalrid M, Romero P et al (1987) A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325:631–635
Liu E, Hjelle B & Bishop JM (1988) Transforming genes in chronic myelogenous leukemia. Proc Natl Acad Sci USA 85:1952–1956
McLaughlin J, Chianese E & Witte ON (1987) In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 84:6558–6562
Mes-Masson A-M, McLaughlin J, Daley GQ, Paskind M & Witte ON (1986) Overlapping cDNA clones define the complete coding region for the P210c-abl-gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci USA 83:9768–9772
Pierce JH, Di Fiore PP, Aaronson, SA et al (1985) Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685–693
Rosenberg N & Witte ON (1988) The viral and cellular forms of the Abelson (abl) oncogene. Adv Virus Res in press
Shtivelman E, Gale RP, Dreazen O, Berrebi A, Zaizov R, Kubonishi I, Miyoshi I & Canaani E (1987) bcr-abl RNA in patients with chronic myelogenous leukemia. Blood 69:971–973
Shtivelman E, Lifshitz B, Gale RP & Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315:550–554
Shtivelman E, Lifshitz B, Gale RP, Roe BA & Canaani E (1986) Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277–284
Schwartz RC, Stanton LW, Riley SC, Marcu KB & Witte ON (1986) Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol 6:3221–3231
Stam K, Heisterkamp N, Grosveld G, de Klein A, Verma R, Coleman M, Dosik H & Groffen J (1985) Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N E J M 313:1429–1433
Whitlock CA, Robertson D & Witte ON (1984) Murine B cell lymphopoiesis in long term culture. J Immunol Meth 67:353–369
Whitlock CA & Witte ON (1982) Long Term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79:3608–3612
Witte ON (1986) Abl oncogene function. Cancer Surveys 5:183–198
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Witte, O.N. (1988). Closely Related BCR/ABL Oncogenes Are Associated with the Distinctive Clinical Biologies of Philadelphia Chromosome Positive Chronic Myelogenous and Acute Lymphocytic Leukemia. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1988. Current Topics in Microbiology and Immunology, vol 141. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74006-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-74006-0_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74008-4
Online ISBN: 978-3-642-74006-0
eBook Packages: Springer Book Archive